%0 Journal Article
%T Improving medical care and prevention in adults with congenital heart disease¡ªreflections on a global problem¡ªpart II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy
%A Christian Schlensak
%A David Celermajer
%A David Pittrow
%A Dirk Lossnitzer
%A Erwin Oechslin
%A Fokko de Haan
%A Hans-Carlo Kallfelz
%A Harald Kaemmerer
%A Jamil Aboulhosn
%A Joerg Schelling
%A Koichiro Niwa
%A Lars Pieper
%A Linda Sanftenberg
%A Michael Weyand
%A Nicole Nagdyman
%A Oeztekin Oto
%A Peter Ewert
%A Renate Oberhoffer
%A Rhoia Neidenbach
%A Stephan Achenbach
%A Thomas Meinertz
%A Ulrike M. M. Bauer
%A Yskert von Kodolitsch
%J SCIE-indexed Journal
%D 2018
%X The exact percentage of IE in the general population is unknown. A scientific statement for healthcare professionals from the American Heart Association quotes an annual incidence ranging from 3¨C7 per 100,000 person-years in the most contemporary population surveys (1-4). The wide range of incidence rates, reported from 1¨C15 cases per 100,000 per year, vary due to different inclusion data. They result from inclusion of different populations at risk, diverse diagnostic criteria and inclusion of cases with ¡°possible¡± IE and referral bias (5-8). Epidemiological studies on IE from hospital case series suffer from selection bias, while well conducted prospective studies from population-based investigations are scarce (6). Amongst adults with CHD the incidence of IE remains according to contemporary reports between 0.91 and 1.32 cases/1,000 patient-years (9,10)
%U http://cdt.amegroups.com/article/view/23025/22177